Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.

Lumen Technologies' exceeded Q4 earnings and revenue expectations. Check out why I think LUMN stock is a long-term investment ...

Consumer spending remains positive and was the major driver of GDP growth in 2024. It will be important to watch for signs of ...

On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...